Vaccination coverage in systemic lupus erythematosus-a cross-sectional analysis of the German long-term study (LuLa cohort)

Rheumatology
Gamal ChehabMatthias Schneider

Abstract

Vaccinations are an important measure to prevent infections in immunocompromised patients. The knowledge of vaccination coverage and reasons for non-vaccination in patients with SLE is scarce. The aim of this study was to assess coverage rates of selected vaccinations in a representative sample of SLE patients and to identify predictors for non-vaccination. In 2013, information on selected vaccinations (coverage, application and reservations) and on demographics, clinical parameters and health beliefs was assessed by means of a self-reported questionnaire among a representative sample of SLE patients in Germany (LuLa cohort). Five hundred and seventy-nine patients participated. Vaccination status was primarily checked by their general practitioner (57.3%). Of all the patients, 24.9% did not get their vaccination status checked at all, 16.1% had generally been advised against the use of vaccinations by a physician, and 37.5% stated that they had rejected vaccinations themselves. Their main reasons were fears of developing a lupus flare (21.8%) or adverse events (13.5%). A greater belief by patients in the doctor controlling one's health and the general benefit of medication prevented the rejection of vaccines. Vaccination covera...Continue Reading

References

Jan 1, 1978·Health Education Monographs·K A WallstonR DeVellis
Mar 29, 2005·Zeitschrift für Rheumatologie·R Fischer-BetzM Schneider
May 18, 2011·Arthritis Care & Research·Jinoos YazdanyPatricia P Katz
Jul 27, 2012·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Eoghan M McCarthySuzanne Donnelly
Oct 10, 2012·Arthritis and Rheumatism·Sonali P DesaiDaniel H Solomon
Aug 10, 2013·Zeitschrift für Rheumatologie·S GoldackerUNKNOWN Kommission Pharmakotherapie der DGRh
Mar 5, 2014·Arthritis & Rheumatology·Lamiae Grimaldi-BensoudaUNKNOWN PGRx Lupus Study Group
Dec 3, 2014·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·Birte BödekerO Wichmann
Oct 3, 2015·Open Forum Infectious Diseases·Keyana N PennantSonali P Desai

❮ Previous
Next ❯

Citations

Dec 13, 2019·Zeitschrift für Rheumatologie·R Fischer-Betz, S Späthling-Mestekemper
Dec 12, 2019·Frontiers in Immunology·Chiara CantarelliPaolo Cravedi
Jan 25, 2021·La Revue de médecine interne·E DavidC Rousset-Jablonski
Jun 18, 2021·Lupus·Alice MasonChristopher J Edwards
Aug 18, 2020·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Shilpa AroraMeenakshi Jolly
Dec 28, 2019·Pediatrics·Vidya SivaramanMonica I Ardura

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.